Articles tagged "Renal failure"

2021 American Transplant Congress
Pre Transplant Estimated Glomerular Filtration Rate and Other Predictors of Mortality and End Stage Kidney Disease After Lung Transplantation
A. Kumar¹, L. N. Bonnell², C. Thomas³
¹Internal Medicine, University of Vermont, Burlington, VT, ²Department of General Internal Medicine Research, University of Vermont, Burlington, VT, ³Internal Medicine, University of Iowa, Iowa City, IA
*Purpose: Lung transplantation is an established treatment for end stage lung disease and as survival has improved, chronic kidney disease (CKD) has become a common…
2021 American Transplant Congress
27 Months Follow Up of a Cohort in the Transplant Continuum After Using a New Electronic Medical Record Tool to Document Transplant Option Discussions Among Patients with EGFR <20 Ml/min/1.73m2
A. A. Yishak¹, M. S. Bhatnagar², A. V. Tomimatsu³, R. La Londe⁴, E. Clark⁵, K. B. Rubenstein⁶, S. Vupputuri⁶
¹MAPMG, McLean, VA, ²Kaiser Permanente |, Oakland, CA, ³Kaiser Permanente, Oakland, CA, ⁴Kaiser Permanente, Oakland,, CA, ⁵Kaiser Permanente, Hyattsville, MD, ⁶MAPRI, Rockville, MD
*Purpose: The purpose of this study was to assess: 1) the documentation of transplant option discussions; 2) the number of members listed & transplanted preemptively;…
2020 American Transplant Congress
Effects of Tenofovir and Entecavir on Glomerular Kidney Function in Liver Transplant Patients: A Nationwide Cohort Study
J. Lee¹, E. Kim¹, S. Yang¹, S. Kim¹, J. Lee¹, J. Park², H. Choi³, B. Kim², D. Joo¹, S. Kim¹, M. Kim¹
¹Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, ²Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, ³Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of
*Purpose: Entecavir and tenofovir are currently the first-line drugs in liver transplantation (LT) patients for the prevention of hepatitis B virus recurrence. Despite its proven…
2020 American Transplant Congress
Evolving Trends in Simultaneous Liver Kidney Transplant (SLKT) – Results from the US SLKT Consortium
G. Cullaro¹, J. Jo², J. Rassiwala², L. Van Wagner², R. Wong³, J. C. Lai³, J. Magee⁴, A. Schluger¹, P. Barman⁵, Y. Patel⁵, K. Walters⁶, S. Biggins⁶, P. Sharma⁴, E. C. Verna¹
¹New York Presbyterian, New York, NY, ²Northwestern University, Chicago, IL, ³UCSF, San Francisco, CA, ⁴University of Michigan, Ann Arbor, MI, ⁵Duke University, Durham, NC, ⁶University of Washington, Seattle, WA
*Purpose: The utilization of SLKT in the United States is rising in the MELD era. We aimed to understand the contemporary changes in characteristics and…
2020 American Transplant Congress
Trends in Liver Transplantation in Patients with Renal Failure Since Implementation of Simultaneous Liver-Kidney Allocation Policy
P. J. Altshuler, O. Shaheen, A. P. Shah, J. Glorioso, A. Frank, C. Ramirez, W. Maley, A. S. Bodzin
Department of Surgery, Thomas Jefferson University, Philadelphia, PA
*Purpose: To reduce potentially unnecessary kidney utilization, as of August 10, 2017 a new allocation policy was implemented restricting Simultaneous Liver Kidney (SLK) transplant to…
2020 American Transplant Congress
Geographical Disparities in Transplantation: Exploring the Association between County Health Rankings and an Individual’s Access to Transplantation
A. J. Carter, R. D. Reed, D. Hendricks, K. N. Baldwin, A. C. Kale, J. E. Locke
Surgery, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Since 2004, living kidney donation has declined, with the southeastern United States disproportionately affected. Programs such as the Living Donor Navigator (LDN), designed to…
2020 American Transplant Congress
No Kidney after Liver Left Behind: An Analysis of the Organ Procurement and Transplantation Network “Safety Net” Policy
T. C. Lee, K. Wima, M. C. Morris, A. Kassam, S. A. Shah, R. Quillin
Surgery, University of Cincinnati, Cincinnati, OH
*Purpose: Liver transplant (LT) recipients who develop persistent renal dysfunction face increased morbidity and mortality. These patients may be eligible for prioritization on the kidney…
2020 American Transplant Congress
Geographic Distribution of End-Stage Renal Disease in the US: The First Description of an “ESRD Belt”
R. D. Reed¹, H. Qu¹, P. A. MacLennan¹, M. N. Mustian¹, D. Anderson¹, A. C. Kale¹, B. J. Orandi¹, B. A. Shelton¹, V. Kumar², M. J. Hanaway¹, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Medicine, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Previous research has demonstrated that population health is associated with organ supply and transplantation; this is particularly true in the southeastern United States, which…
2020 American Transplant Congress
Beyond the Margin: Using Kidneys from Donors on Dialysis
P. S. Patel¹, S. Karir², V. R. Peddi¹, H. Mahanty¹, S. Katznelson¹, J. Bellingham¹, N. Neidlinger¹, A. Hassoun¹, A. Sandhu¹, N. Garg¹, L. Mayen³, W. Bry¹
¹CPMC Dept of Transplantation, San Francisco, CA, ²Lewis and Clark College, Portland, OR, ³Donor Network West, San Ramon, CA
*Purpose: Outcomes for transplantation from donors with acute kidney injury have been favorable. The definition and severity of AKI have been variable. Donors who are…
2020 American Transplant Congress
Acute on Chronic Liver Failure (ACLF) Patients Have a Dynamic and Progressive Clinical Course Until Receiving a Liver Transplant: A 5-Year Study at the National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico
E. Cervantes-Alvarez¹, M. J. Lizardo-Thiebaud¹, E. Alatorre-Arenas¹, O. Mendez-Guerrero¹, S. Yarza-Regalado¹, A. Torre¹, M. Vilatobá², D. Kershenobich¹, C. A. Huang³, N. Navarro-Alvarez¹
¹Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ²Surgery, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ³Surgery, University of Colorado Anschutz Medical Campus, DENVER, CO
*Purpose: To characterize the clinical course of patients diagnosed with acute on chronic liver failure (ACLF) before undergoing liver transplantation. ACLF is characterized by an…